ACR Convergence 2021

Serum urate concentration is a valid treatment target for reducing or eliminating gout flares supporting a treat-to-target approach for managing the condition, according to a new analysis presented at ACR Convergence 2021. An international research team, led by rheumatologist Professor Lisa...

Serum urate concentration is a valid treatment target for reducing or eliminating gout flares supporting a treat-to-target approach for managing...

The IL-17A inhibitor secukinumab has shown a high sustained remission rate in biologic-naive patients with new onset or relapsing giant cell arteritis (GCA). Dr Jens Thiel, from the University Hospital Freiburg in Germany, told the ACR Convergence meeting that IL-6 inhibition...

The IL-17A inhibitor secukinumab has shown a high sustained remission rate in biologic-naive patients with new onset or relapsing giant...

The biological DMARD abatacept used in the treatment of rheumatoid arthritis patients has been associated with increased rates of non-melanoma skin cancer (NMSC), according to a German study. The findings, presented at ACR Convergence, support similar results from a Swedish...

The biological DMARD abatacept used in the treatment of rheumatoid arthritis patients has been associated with increased rates of non-melanoma...